Biotricity surpasses $10 million in annual revenue run rate

REDWOOD CITY, Calif., Nov 21, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…

Expansion

Biotricity provides updates on its operational and expansion strategy

REDWOOD CITY, Calif., Nov 18, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…

Boxes ready for distribution

Biotricity signs Distribution Agreement to expand access for its Cardiac Monitoring Solutions

REDWOOD CITY, Calif., Nov 16, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…

Biotricity reports financial results for Fiscal 2023 Second Quarter

REDWOOD CITY, Calif., Nov 14, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…

Bioheart in the Times list of best inventions 2022

Biotricity’s Bioheart named to TIME’s list of The Best Inventions of 2022

REDWOOD CITY, Calif., Nov 10, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…

Fiscal Second Quarter

Biotricity to host Fiscal 2023 Second Quarter financial results on November 14th at 4:30 PM ET

REDWOOD CITY, Calif., Nov 01, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…

Biocare Cardiac

Biotricity launches Cardiac Disease Management Solution following 2 successful pilots with Oklahoma & Kentucky Clinics

REDWOOD CITY, Calif., Oct 26, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…

American Medical Device Summit

Biotricity CEO, Waqaas Al-Siddiq, to participate in panel discussion on the evolution of medical devices at the American Medical Device Summit on October 19th

REDWOOD CITY, Calif., Oct 11, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…

Biotricity surpasses 2 billion recorded and analyzed heartbeats for atrial fibrillation (AFib)

REDWOOD CITY, Calif., Oct 04, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…

bioflux-ai

Biotricity wins NIH Grant from the National Heart, Blood, and Lung Institute for AI-Enabled real-time monitoring and predictive analytics for stroke due to chronic kidney failure

REDWOOD CITY, Calif., Sep 07, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…

Fiscal First Quarter 2023

Biotricity reports financial results for Fiscal 2023 First Quarter

REDWOOD CITY, Calif., Aug 15, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), ("Biotricity" or the "Company"), a medical diagnostic and…

Fiscal First Quarter 2023

Biotricity to host Fiscal First Quarter 2023 financial results conference call on August 15th at 4:30 p.m. ET

REDWOOD CITY, Calif., Aug 05, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…